Literature DB >> 10291478

A QALY is a QALY--or is it?

M C Weinstein.   

Abstract

Mesh：

Year:  1988        PMID： 10291478     DOI： 10.1016/0167-6296(88)90030-6

Source DB:  PubMed          Journal:  J Health Econ        ISSN： 0167-6296            Impact factor:   3.883


× No keyword cloud information.
  26 in total

Review 1.  On individual preferences and aggregation in economic evaluation in healthcare.

Authors:  B Liljas; B Lindgren
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Clinical trials in orthopaedics research. Part III. Overcoming operational challenges in the design and conduct of randomized clinical trials in orthopaedic surgery.

Authors:  Elena Losina; James Wright; Jeffrey N Katz
Journal:  J Bone Joint Surg Am       Date:  2012-03-21       Impact factor: 5.284

3.  Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US.

Authors:  John F P Bridges; Eberechukwu Onukwugha; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

4.  Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability.

Authors:  Anthony T Newall; Juan Pablo Dehollain; Prudence Creighton; Philippe Beutels; James G Wood
Journal:  Pharmacoeconomics       Date:  2013-08       Impact factor: 4.981

Review 5.  The Value of Medicines: A Crucial but Vague Concept.

Authors:  Fernando Antoñanzas; Robert Terkola; Maarten Postma
Journal:  Pharmacoeconomics       Date:  2016-12       Impact factor: 4.981

Review 6.  Public drug policy for children in Canada.

Authors:  Avram E Denburg; Wendy J Ungar; Mark Greenberg
Journal:  CMAJ       Date:  2017-07-31       Impact factor: 8.262

Review 7.  OARSI Clinical Trials Recommendations: Key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis.

Authors:  E Losina; J Ranstam; J E Collins; T J Schnitzer; J N Katz
Journal:  Osteoarthritis Cartilage       Date:  2015-05       Impact factor: 6.576

8.  Health Inequalities: To What Extent are Decision-Makers and Economic Evaluations on the Same Page? An English Case Study.

Authors:  Sebastian Hinde; Dan Howdon; James Lomas; Matthew Franklin
Journal:  Appl Health Econ Health Policy       Date:  2022-06-29       Impact factor: 2.561

9.  Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.

Authors:  Ayman I Omar; Warren P Mason
Journal:  Core Evid       Date:  2010-06-15

10.  How to assess the value of medicines?

Authors:  Steven Simoens
Journal:  Front Pharmacol       Date:  2010-09-07       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.